20170406 Telix Logo.png
Telix Pharmaceuticals submits European marketing authorisation application for prostate cancer imaging product
April 30, 2020 20:14 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE, Belgium, May 01, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that it has submitted a marketing...
20170406 Telix Logo.png
Telix Pharmaceuticals and GE Healthcare: Maximising 68Ga Supply for Prostate Cancer Imaging
October 13, 2019 19:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Oct. 14, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX, “Telix”, the “Company”) a clinical-stage biopharmaceutical company focused on the development of...
20170406 Telix Logo.png
Telix Pharmaceuticals to Launch Japanese Renal Cancer Imaging Study
August 29, 2019 20:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO, Japan, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the...
20170406 Telix Logo.png
Telixが日本で腎臓がん用画像診断薬の臨床治験を開始
August 29, 2019 20:00 ET | Telix Pharmaceuticals Limited
メルボルン, オーストラリア および京都, 日本, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals...
20170406 Telix Logo.png
Telix Pharmaceuticals to Present at Jefferies Healthcare Conference
June 03, 2019 08:54 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the...
Telix Group Expands Prostate Imaging Capability through ININ Technology Partnership
January 23, 2019 19:15 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIEGE, Belgium, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Advanced Nuclear Medicine Ingredients SA (“ANMI”), a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX:TLX,...
Telix Group Expands Prostate Imaging Capability through ININ Technology Partnership
January 23, 2019 19:15 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIEGE, Belgium, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Advanced Nuclear Medicine Ingredients SA (“ANMI”), a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX:TLX,...
20170406 Telix Logo.png
Telix Pharmaceuticals Launches illumet™ Microsite (Kit for the Preparation of 68Ga-PSMA)
January 23, 2019 08:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix Group”, “Company”), a clinical-stage biopharmaceutical company focused on the...
20170406 Telix Logo.png
Telix and Nihon Medi-Physics to Collaborate on Actinium Renal Cancer Therapeutics
November 28, 2018 18:17 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
20170406 Telix Logo.png
テリックスと日本メジフィジックスが アクチニウム標識腎癌治療薬の開発を目指した技術提携契約を締結
November 28, 2018 18:17 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited(本社:オーストラリア メルボルン、CEO:Dr. Christian...